Evidence map›Paper›PMID 36061832›Full record

ArticleThe EPMA journal2022

Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine.

Bo Ram Kim, Tae Keun Yoo, Hong Kyu Kim, Ik Hee Ryu, Jin Kuk Kim, In Sik Lee, Jung Soo Kim, Dong-Hyeok Shin, Young-Sang Kim, Bom Taeck Kim

Open access · greenAbstract read
In one paragraph

Article in The EPMA journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Pain Increases the Risk for Sarcopenia in Community-Dwelling Adults: Results From the English Longitudinal Study of Ageing.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bo Ram KimDepartment of Ophthalmology, Hangil Eye Hospital, Incheon, Republic of Korea.
Tae Keun YooB&VIIT Eye Center, B2 GT Tower, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, Republic of Korea.ORCID 0000-0003-0890-8614
Hong Kyu KimDepartment of Ophthalmology, Dankook University College of Medicine, Dankook University Hospital, Cheonan, Republic of Korea.
Ik Hee RyuB&VIIT Eye Center, B2 GT Tower, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, Republic of Korea.
Jin Kuk KimB&VIIT Eye Center, B2 GT Tower, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, Republic of Korea.
In Sik LeeB&VIIT Eye Center, B2 GT Tower, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, Republic of Korea.
Jung Soo KimVISUWORKS, Seoul, Republic of Korea.
Dong-Hyeok ShinMalgeun Seoul Family Clinic, Seoul, Republic of Korea.
Young-Sang KimDepartment of Family Medicine, CHA Bundang Medical Centre, CHA University, Seongnam, Republic of Korea.
Bom Taeck KimDepartment of Family Practice & Community Health, Ajou University School of Medicine, Suwon, Gyeonggi-do 16499 Republic of Korea.ORCID https://orcid.org/0000-0002-0395-0410
Nune Eye Hospital · KRCHA University Bundang Medical Center · KRDankook University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Sarcopenia is characterized by a gradual loss of skeletal muscle mass and strength with increased adverse outcomes. Recently, large-scale epidemiological studies have demonstrated a relationship between several chronic disorders and ocular pathological conditions using an oculomics approach. We hypothesized that sarcopenia can be predicted through eye examinations, without invasive tests or radiologic evaluations in the context of predictive, preventive, and personalized medicine (PPPM/3PM). Methods: We analyzed data from the Korean National Health and Nutrition Examination Survey (KNHANES). The training set (80%, randomly selected from 2008 to 2010) data were used to construct the machine learning models. Internal (20%, randomly selected from 2008 to 2010) and external (from the KNHANES 2011) validation sets were used to assess the ability to predict sarcopenia. We included 8092 participants in the final dataset. Machine learning models (XGBoost) were trained on ophthalmological examinations and demographic factors to detect sarcopenia. Results: In the exploratory analysis, decreased levator function (odds ratio [OR], 1.41; Conclusion: Sarcopenia is treatable before the vicious cycle of sarcopenia-related deterioration begins. Therefore, early identification of individuals at a high risk of sarcopenia is essential in the context of PPPM. Our oculomics-based approach provides an effective strategy for sarcopenia prediction. The proposed method shows promise in significantly increasing the number of patients diagnosed with sarcopenia, potentially facilitating earlier intervention. Through patient oculometric monitoring, various pathological factors related to sarcopenia can be simultaneously analyzed, and doctors can provide personalized medical services according to each cause. Further studies are needed to confirm whether such a prediction algorithm can be used in real-world clinical settings to improve the diagnosis of sarcopenia. Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-022-00292-3.

Indexed as

Age-related macular degenerationBlepharoptosisCataractDemographic factorsMachine learningMarker patternsOculomicsOphthalmologic examinationPredictive algorithmPredictive model for practitionersPredictive preventive personalized medicine (PPPM / 3PM), SarcopeniaRisk assessment

Identifiers

PMID36061832
PMCPMC9437169
OpenAlexW4290653018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.